Nanjing Vishee Medical Technology Co Ltd (SHG:688580) — Market Cap & Net Worth
Market Cap & Net Worth: Nanjing Vishee Medical Technology Co Ltd (688580)
Nanjing Vishee Medical Technology Co Ltd (SHG:688580) has a market capitalization of $676.05 Million (CN¥4.62 Billion) as of August 25, 2026. Listed on the SHG stock exchange, this China-based company holds position #10809 globally and #2931 in its home market, demonstrating a -3.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nanjing Vishee Medical Technology Co Ltd's stock price CN¥48.24 by its total outstanding shares 95771288 (95.77 Million). Check Nanjing Vishee Medical Technology Co Ltd (688580) share price today for real-time trading data and today's change.
Nanjing Vishee Medical Technology Co Ltd Market Cap History: 2020 to 2026
Nanjing Vishee Medical Technology Co Ltd's market capitalization history from 2020 to 2026. Data shows change from $1.32 Billion to $676.05 Million (-18.48% CAGR).
Nanjing Vishee Medical Technology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nanjing Vishee Medical Technology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 688580 total equity to evaluate the company's book value and shareholders' equity.
Latest Price to Sales (P/S) Ratio
1.47x
Nanjing Vishee Medical Technology Co Ltd's market cap is 1.47 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.96x
Nanjing Vishee Medical Technology Co Ltd's market cap is 4.96 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.32 Billion | $378.37 Million | $143.66 Million | 3.48x | 9.16x |
| 2021 | $1.42 Billion | $430.04 Million | $177.81 Million | 3.30x | 7.97x |
| 2022 | $704.95 Million | $321.62 Million | $93.83 Million | 2.19x | 7.51x |
| 2023 | $853.00 Million | $462.22 Million | $136.26 Million | 1.85x | 6.26x |
| 2024 | $391.14 Million | $400.06 Million | $101.97 Million | 0.98x | 3.84x |
| 2025 | $678.29 Million | $462.73 Million | $136.63 Million | 1.47x | 4.96x |
Competitor Companies of 688580 by Market Capitalization
Companies near Nanjing Vishee Medical Technology Co Ltd in the global market cap rankings as of August 25, 2026. Also see Nanjing Vishee Medical Technology Co Ltd (688580) cash conversion ratio for how efficiently the company converts equity into cash flow.
Key companies related to Nanjing Vishee Medical Technology Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #105 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #195 globally with a market cap of $126.37 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #232 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #249 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #105 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $116.64 |
| #195 | Stryker Corporation | NYSE:SYK | $126.37 Billion | $329.45 |
| #232 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.35 |
| #249 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Nanjing Vishee Medical Technology Co Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Nanjing Vishee Medical Technology Co Ltd's market cap moved from $1.32 Billion to $ 676.05 Million, with a yearly change of -18.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥676.05 Million | -0.33% |
| 2025 | CN¥678.29 Million | +73.41% |
| 2024 | CN¥391.14 Million | -54.15% |
| 2023 | CN¥853.00 Million | +21.00% |
| 2022 | CN¥704.95 Million | -50.28% |
| 2021 | CN¥1.42 Billion | +7.70% |
| 2020 | CN¥1.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 24th, 2026 the market cap of Nanjing Vishee Medical Technology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $676.05 Million USD |
| MoneyControl | $676.05 Million USD |
| MarketWatch | $676.05 Million USD |
| marketcap.company | $676.05 Million USD |
| Reuters | $676.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nanjing Vishee Medical Technology Co Ltd
Nanjing Vishee Medical Technology Co., Ltd provides rehabilitation meditation products and solutions in China and internationally. The company offers MagNeuro, a transcranial magnetic stimulation (TMS) device, and MagNeuro ONE, a TMS therapy system with navigation for psychiatric and neurological applications. It also provides MagBelle, a pelvic floor muscle stimulator for the treatment of urinar… Read more